B. Sozeri Et Al. , "The feasibility of withdrawing canakinumab in paediatric colchicine-resistant familial Mediterranean fever patients," CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.39, no.5, 2021
Sozeri, B. Et Al. 2021. The feasibility of withdrawing canakinumab in paediatric colchicine-resistant familial Mediterranean fever patients. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.39, no.5 .
Sozeri, B., Sonmez, H. E., Karadag, S. G., Baglan, E., Ozturk, K., Cakan, M., ... Demir, F.(2021). The feasibility of withdrawing canakinumab in paediatric colchicine-resistant familial Mediterranean fever patients. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.39, no.5.
Sozeri, B. Et Al. "The feasibility of withdrawing canakinumab in paediatric colchicine-resistant familial Mediterranean fever patients," CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.39, no.5, 2021
Sozeri, B. Et Al. "The feasibility of withdrawing canakinumab in paediatric colchicine-resistant familial Mediterranean fever patients." CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.39, no.5, 2021
Sozeri, B. Et Al. (2021) . "The feasibility of withdrawing canakinumab in paediatric colchicine-resistant familial Mediterranean fever patients." CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.39, no.5.
@article{article, author={B. Sozeri Et Al. }, title={The feasibility of withdrawing canakinumab in paediatric colchicine-resistant familial Mediterranean fever patients}, journal={CLINICAL AND EXPERIMENTAL RHEUMATOLOGY}, year=2021}